Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
AGO_2022E_14_Supportive Care and Managment of Side Effects_MASTER_schwarz_final
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions
Uwe M. Martens Editor Third Edition
The Use of Phospholipids to Make Pharmaceutical Form Line Extensions - Hoogevest - 2021 - European Journal of Lipid Science and Technology - Wiley Online Library
Anhang
AGO_2022D_14_Supportive Therapie und NW-Management_REF
Folie 1
AGO_2022D_14_Supportive Therapie und NW-Management_REF
Evaluation of allogeneic Transplantation in Patients above the age of 60 years with High Risk Acute Myeloid Leukemia (ETAL-2)
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
ALL-Trans Retinoic Acid (ATRA) in the Treatment of Myelodysplastic Syndromes: Results in 5 Cases
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Cytarabine - Wikipedia
Evaluation of allogeneic Transplantation in Patients above the age of 60 years with High Risk Acute Myeloid Leukemia (ETAL-2)
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Pharmacotherapy in Children and Adolescents: Oncology | SpringerLink
MATRIX / High-dose chemotherapy and autologous stem cell transplant or consolidating conventional chemotherapy in primary CNS ly
Evaluation of allogeneic Transplantation in Patients above the age of 60 years with High Risk Acute Myeloid Leukemia (ETAL-2)
Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
AGO_2022D_14_Supportive Therapie und NW-Management_REF
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
